HOTH Q1 2021 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-6.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$21M

Total Liabilities

$1M

Stockholders' Equity

$20M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$305	+100.0%
Operating Income	-$4M	-$2M	-135.0%
Net Income	-$4M	-$2M	-133.3%